Phase 1 Study of 162, a Novel Neutralizing Antibody Targeting Hepatitis B Surface Antigen, in Healthy Adult Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Chronic Hepatitis B
Related studies linked through entity extraction aliases.
Ethnobridging Study in Healthy Volunteers, Chinese and Japanese Subjects
- Status
- TERMINATED
- Phase
- PHASE1
Performance of Novel Simplified Score for Chronic Hepatitis B Treatment Eligibility in Thailand
- Status
- UNKNOWN
- Phase
- N/A
Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis B
- Status
- COMPLETED
- Phase
- PHASE4
A phase4 Clinical Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Disoproxil From Tenofovir Disoproxil Fumarate in Patients With Chronic Hepatitis B
- Status
- COMPLETED
- Phase
- PHASE4
A Pharmacokinetic Study to Evaluate the Drug Interaction Between HRS5091 and Probe Drugs in Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Disease Loads and Status of Treatment
- Status
- UNKNOWN
- Phase
- N/A
A Study of Hepalatide Combined With TAF and PEG-IFN as Finite Treatment of Chronic Hepatitis B Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Safety and Efficacy of ATI-2173 and Vebicorvir in Combination With Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B Virus Infection
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388(2) in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
A Study of LP-128 Capsules in Healthy Subjects
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Single and Repeated Dose Escalation of RBD1016 in Subjects with Chronic Hepatitis B Virus (HBV) Infection
- Status
- COMPLETED
- Phase
- PHASE1
A Study of ALG-020572 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single Doses in Healthy Volunteers and Multiple Doses in CHB Subjects
- Status
- TERMINATED
- Phase
- PHASE1
The Efficacy and Safety of 12-week SOF/VEL Regimen Combined With Prophylactic Use of TAF for Treatment-naïve Genotype 1-6 HCV/HBV Co-infection Adult Patients With or Without Compensated Cirrhosis in China
- Status
- UNKNOWN
- Phase
- PHASE4
Effort to Narrow the Gap Between in Accordance With Guidelines and Consent to Treat CHB Population in East of China
- Status
- UNKNOWN
- Phase
- NA
Open-Label Study of AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a in Subjects With Chronic Hepatitis B Infection
- Status
- COMPLETED
- Phase
- PHASE2
Regression of Liver Fibrosis by Tenofovir Alafenamide (TAF)
- Status
- UNKNOWN
- Phase
- PHASE4
Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B
- Status
- RECRUITING
- Phase
- N/A
Study to Evaluate the Safety and Efficacy of Selgantolimod (SLGN)-Containing Combination Therapies for the Treatment of Chronic Hepatitis B (CHB)
- Status
- COMPLETED
- Phase
- PHASE2